Eisai chooses UK for key European base
Japanese health care firm Eisai will make Hatfield its European headquarters, in a major £75 million (€105 million) investment that demonstrates the UK's appeal for big pharmaceutical companies.
Archives for February 1, 2006
Kidney disease lab research points to new therapies
Scientists have reported a discovery at the cellular level that suggests possibilities for drug therapy for kidney disease. This discovery could open up new avenues of laboratory research into the disease that could help the 600,000 people in the US...
Researchers optimise vein spotting
Scientists at the Georgia Institute of Technology have developed a small handheld device that makes finding veins easier and quicker, saving time and money.
Sud-Chemie enters new markets with joint venture
Munich-based Sud-Chemie is set to expand its pharmaceutical packaging business to German-speaking markets with a joint venture with Swiss company Plaspaq SA.
Top contenders for manufacturing accolade revealed
AstraZeneca, Baxter BioPharma Solutions, Daiichi Asubio Pharma, Janssen Pharmaceutica and Wyeth Pharmaceuticals are the finalists competing for this year's Facility of the Year Award, which recognizes innovation and cost effectiveness utilised by...
In-PharmaTechnologist insulin series
FDA fires the starting gun for Exubera
On your marks, get set go! The FDA has fired the starting gun and Pfizer is finally off and running after the long-awaited approval of Exubera - the world's first non-injectable insulin - expected to hit the US market by mid-year and Europe shortly after.